The Clinical Guidelines Program is a longstanding, collaborative effort of the New York State Department of Health (NYSDOH) AIDS Institute (AI), Office of the Medical Director (OMD), and the Johns Hopkins University (JHU) School of Medicine, Division of Infectious Diseases.
Mission: To develop and disseminate practical, evidence-based clinical guidelines that promote quality medical care for people in New York who are living with and/or are at risk of acquiring HIV, HCV, STIs and substance use.
Expert committees: AIDS Institute clinical guidelines are developed by committees of expert New York State clinicians. Committee members collaborate to survey and evaluate peer-reviewed literature, write and assess clinical recommendations, and update existing guidelines or create new guidelines as necessary to ensure that recommendations reflect current best practices. All new and revised guidelines undergo peer and consumer review.
Evidence-based recommendations: Committee members apply their expertise and experience in evaluating factors that determine treatment decisions, including potential benefits and outcomes, risks, and burdens to the patient; patient views, values, and preferences; feasibility and tolerability; and the quality of evidence supporting a treatment recommendation. All recommendations are assigned ratings based on the strength and quality of the supporting evidence.
Audience: AIDS Institute clinical care guidelines are produced and disseminated to clinicians in New York who provide prevention services and medical care to people who are living with or at risk of acquiring HIV, HCV, STIs and substance use.
Stay Up-To-Date with the Clinical Guidelines Program: Subscribe to Topics, Trends & Updates to receive an email announcement when new guidelines or updates to guidelines are published, along with highlights from hot topics and events, and trends in guideline use. Subscribe now
Let Us Know What You Think: Complete our brief survey to give feedback on the guidelines and the website. Complete the survey now
- Medscape Commentary: Growing Old With HIV: Beyond Just Surviving (9/17/20)
- Topics, Trends & Updates (9/3/20)
- Guidance: Rapid ART Initiation During COVID-19 (8/26/20)
- Updated: Diagnosis and Management of Acute HIV (8/26/2020)
- Updated: Treatment of Chronic With DAAs (8/17/20)
- NYS Good Practices to Prevent Perinatal HIV Transmission (8/10/20)
- NYS Good Practices in Managing Infant Perinatal HIV Exposure (8/10/20)
- New: Guidance for Addressing the Needs of Older Patients in HIV Care (7/31/20)
- NYC DOHMH: Dear Colleague COVID-19 Updates, Dermatologic Manifestations Associated With COVID-19 (9/24/20)
- FDA MedWatch: Certain COVID-19 Serology/Antibody Tests Should Not Be Used - Letter to Clinical Laboratory Staff and Health Care Providers (6/24/20)
- NYC Health: COVID-19 Prevention and Groups at Higher Risk (6/11/20)
- CDC: What to Know About HIV and COVID-19 (6/4/20)
- NASTAD: Accountability as a Public Health Response: COVID-19’s Impact on Communities of Color (6/4/20)
Current Evidence Suggests Well-Controlled HIV May Not Increase COVID-19 Mortality: As hope that the COVID-19 pandemic would fade after a few months gives way to the reality that spread is likely to persist for some time, knowledge about risks is steadily accumulating . . . Read more
Long-Acting Cabotegravir and Rilpivirine for Maintenance of HIV-1 Suppression: Many clinicians provide care for patients who struggle with taking enough of their antiretroviral therapy (ART) to maintain a consistently undetectable viral load . . . Read more
- 10/19/20: NMAC: Unites States Conference on HIV/AIDS (USCHA) (Virtual)
- 10/21/20: IDWeek (Virtual)
- 10/25/20: NYSDOH AI: PrEP Aware Week: This is why I PrEP
- 11/11/20: ANAC2020 VIRTUAL CONFERENCE (Virtual)
- 12/01/20: MA AETC: World AIDS Day Conference: Trauma in the Time of HIV and COVID-19: Clinical Issues with Trauma, HIV, and COVID-19 (Virtual)
- 9/30/20: CEI: NYS HIV Primary Care and Prevention Center of Excellence & #MEAction New York: Post-Viral Syndrome and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): What Every Clinician Needs to Know
- 9/30/20: CEI Sexual Health Center of Excellence ECHO: Sex Trafficking, Violence and the Pandemic
- 9/30/20: NYSDOH AI and CCHRPP: ETE Learning Series: Increase in Hepatitis C and Congenital Syphilis: The Other Consequences of the Opioid Epidemic
- 9/30/20: MA AETC: Increasing Screening for Infectious Disease in Opioid Treatment: Special Populations in OTPs – Pregnant Women and Family Planning
- 10/02/20: NECA AETC: Anticoagulation Medication Update: A Focus on Patients with HIV